miR-888 in MCF-7 Side Population Sphere Cells Directly Targets E-cadherin

a.
Key Laboratory of Molecular and Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China
b.
The Department of Urology of PLA 309 Hospital, Beijing 100091, China

More Information

Corresponding author: E-mail address: lbchen@genetics.ac.cn (Liangbiao Chen)

These authors contributed equally to this work.

摘要

- /
- /
- /
- /
Abstract: Side population (SP) cells are a small subset of cells isolated from a cultured cancer cell line that exhibit characteristics similar to those of cancer stem cells (CSCs), such as high metastatic and tumorigenic potential. The molecular mechanisms that give rise to the malignant properties of SP cells are not clear. We isolated SP cells from the MCF-7 breast cancer cell line and profiled microRNA (miRNA) expression patterns between SP cell-derived spheroids and non-SP cells. SP spheroids were found to possess 42 up-regulated miRNAs and 27 down-regulated ones (above 5-fold changes). One of the up-regulated miRNAs, miR-888 computationally predicted to participate in the adherens junction (AJ) pathway, was investigated. Over-expression of miR-888 in MCF-7 cells reduced the mRNA levels of all four AJ pathway genes (E-cadherin, ACTG1, PTPRT and CDC42) that were selected for testing, whereas knocking down miR-888 reversed the trends. Western blot and flow cytometric quantitation of the membrane E-cadherin levels showed the same trend of change under these treatments. Luciferase reporter assay showed E-cadherin is a direct target of miR-888. As a potential role in intercellular adhesiveness and maintenance of malignant tissue architecture, the results indicate that miR-888 is a repressor of the AJ pathway in MCF-7 cells and that up-regulation of miR-888 contributes to aggressiveness in MCF-7 SP cells.
- Side population /
- Cancer stem cell /
- MicroRNA /
- Adherens junction /
- Cancer metastasis
These authors contributed equally to this work.
注释:

HTML全文

参考文献(36)

[1]	Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A. et al. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. USA, 100 (2003),pp. 3983-3988
[2]	Calin, G.A., Croce, C.M. MicroRNA signatures in human cancers Nat. Rev. Cancer, 6 (2006),pp. 857-866
[3]	Campbell, L.L., Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle, 6 (2007),pp. 2332-2338
[4]	Chiba, T., Kita, K., Zheng, Y.W. et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties Hepatology, 44 (2006),pp. 240-251
[5]	Engelmann, K., Shen, H., Finn, O.J. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1 Cancer Res., 68 (2008),pp. 2419-2426
[6]	Fong, M.Y., Kakar, S.S. The role of cancer stem cells and the side population in epithelial ovarian cancer Histol. Histopathol., 25 (2010),pp. 113-120
[7]	Garzon, R., Marcucci, G., Croce, C.M. Targeting microRNAs in cancer: rationale, strategies and challenges Nat. Rev. Drug Discov., 9 (2010),pp. 775-789
[8]	Goodell, M.A., Brose, K., Paradis, G. et al. J. Exp. Med., 183 (1996),pp. 1797-1806
[9]	Heppner, G.H. Tumor heterogeneity Cancer Res., 44 (1984),pp. 2259-2265
[10]	Hermann, P.C., Huber, S.L., Herrler, T. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell, 1 (2007),pp. 313-323
[11]	Hermiston, M.L., Wong, M.H., Gordon, J.I. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system Genes Dev., 10 (1996),pp. 985-996
[12]	Ho, M.M., Ng, A.V., Lam, S. et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells Cancer Res., 67 (2007),pp. 4827-4833
[13]	Huang, B., Huang, Y.J., Yao, Z.J. et al. Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P PLoS ONE, 8 (2013),p. e68293
[14]	Jordan, C.T., Guzman, M.L., Noble, M. Cancer stem cells N. Engl. J. Med., 355 (2006),pp. 1253-1261
[15]	Kim, S.H., Li, Z., Sacks, D.B. E-cadherin-mediated cell-cell attachment activates Cdc42 J. Biol. Chem., 275 (2000),pp. 36999-37005
[16]	Korpal, M., Lee, E.S., Hu, G. et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J. Biol. Chem., 283 (2008),pp. 14910-14914
[17]	Li, F., Tiede, B., Massagué, J. et al. Beyond tumorigenesis: cancer stem cells in metastasis Cell Res., 17 (2006),pp. 3-14
[18]	Liu, C., Kelnar, K., Liu, B. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Nat. Med., 17 (2011),pp. 211-215
[19]	Lynch, H.T., Watson, P., Lynch, J.F. et al. Hereditary ovarian cancer: heterogeneity in age at onset Cancer, 71 (1993),pp. 573-581
[20]	Ma, L., Young, J., Prabhala, H. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat. Cell Biol., 12 (2010),pp. 247-256
[21]	Marusyk, A., Polyak, K. Tumor heterogeneity: causes and consequences Biochim. Biophys. Acta., 1805 (2010),pp. 105-117
[22]	McLachlan, R.W. Protein tyrosine phosphatase activity is necessary for E-cadherin-activated Src signaling Cytoskeleton, 68 (2011),pp. 32-43
[23]	Obernosterer, G., Martinez, J., Alenius, M. Nat. Protoc., 2 (2007),pp. 1508-1514
[24]	Pece, S., Tosoni, D., Confalonieri, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content Cell, 140 (2010),pp. 62-73
[25]	Reya, T., Morrison, S.J., Clarke, M.F. et al. Stem cells, cancer, and cancer stem cells Nature, 414 (2001),pp. 105-111
[26]	Roggli, V.L., Vollmer, R.T., Greenberg, S.D. et al. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases Hum. Pathol., 16 (1985),pp. 569-579
[27]	Salcido, C., Larochelle, A., Taylor, B. et al. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer Br. J. Cancer, 102 (2010),pp. 1636-1644
[28]	Sell, S. Heterogeneity and plasticity of hepatocyte lineage cells Hepatology, 33 (2001),pp. 738-750
[29]	Shi, M., Guo, N. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer Cancer Treat. Rev., 35 (2009),pp. 328-334
[30]	Shipitsin, M., Campbell, L.L., Argani, P. et al. Molecular definition of breast tumor heterogeneity Cancer Cell, 11 (2007),pp. 259-273
[31]	Singh, S.K., Hawkins, C., Clarke, I.D. et al. Identification of human brain tumour initiating cells Nature, 432 (2004),pp. 396-401
[32]	Symmans, W.F., Liu, J., Knowles, D.M. et al. Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions Hum. Pathol., 26 (1995),pp. 210-216
[33]	Thomson, J.M., Parker, J., Perou, C.M. et al. A custom microarray platform for analysis of microRNA gene expression Nat. Methods, 1 (2004),pp. 47-53
[34]	Visvader, J.E. Cells of origin in cancer Nature, 469 (2011),pp. 314-322
[35]	Wang, H.J., Guo, Y.Q., Tan, G. et al. MiR-125b regulates side population in breast cancer and confers a chemoresistant phenotype J. Cell. Biochem., 114 (2013),pp. 2248-2257
[36]	Wang, Y., Yu, Y., Tsuyada, A. et al. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM Oncogene, 30 (2010),pp. 1470-1480